Publications

Journals

Prod'homme V; Griffin C; Aicheler RJ; Wang EC; McSharry BP; Rickards CR; Stanton RJ; Borysiewicz LK; et alLópez-Botet M; Wilkinson GW; Tomasec P. (1 Apr 2007). The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cells. J Immunol. 178:4473-4481.
Wall SR; Scherf CF; Morison L; Hart KW; West B; Ekpo G; Fiander AN; Man S; et alGelder CM; Walraven G; Borysiewicz LK. (31 Oct 2005). Cervical human papillomavirus infection and squamous intraepithelial lesions in rural Gambia, West Africa: viral sequence analysis and epidemiology. Br J Cancer. 93:1068-1076. DOI.
Lack N; West B; Jeffries D; Ekpo G; Morison L; Soutter WP; Walraven G; Borysiewicz L. (1 Jun 2005). Comparison of non-invasive sampling methods for detection of HPV in rural African women. SEX TRANSM INFECT. 81:239-241. DOI.
Gelder CM; Williams OM; Hart KW; Wall S; Williams G; Ingrams D; Bull P; Bunce M; et alWelsh K; Marshall SE; Borysiewicz L. (Feb 2003). HLA class II polymorphisms and susceptibility to recurrent respiratory papillomatosis. J Virol. 77:1927-1939. Open Access copy.
Wang EC; McSharry B; Retiere C; Tomasec P; Williams S; Borysiewicz LK; Braud VM; Wilkinson GW. (28 May 2002). UL40-mediated NK evasion during productive infection with human cytomegalovirus. Proc Natl Acad Sci U S A. 99:7570-7575. DOI.
Moutaftsi M; Mehl AM; Borysiewicz LK; Tabi Z. (15 Apr 2002). Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. Blood. 99:2913-2921.
Vekemans J; Ota MO; Wang EC; Kidd M; Borysiewicz LK; Whittle H; McAdam KP; Morgan G; et alMarchant A. (Mar 2002). T cell responses to vaccines in infants: defective IFNgamma production after oral polio vaccination. Clin Exp Immunol. 127:495-498.
Sathish JG; Johnson KG; LeRoy FG; Fuller KJ; Hallett MB; Brennan P; Borysiewicz LK; Sims MJ; et alMatthews RJ. (Dec 2001). Requirement for CD28 co-stimulation is lower in SHP-1-deficient T cells. Eur J Immunol. 31:3649-3658. DOI.
Evans M; Borysiewicz LK; Evans AS; Rowe M; Jones M; Gileadi U; Cerundolo V; Man S. (1 Nov 2001). Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6. J Immunol. 167:5420-5428.
Lawson TM; Man S; Wang EC; Williams S; Amos N; Gillespie GM; Moss PA; Borysiewicz LK. (Nov 2001). Functional differences between influenza A-specific cytotoxic T lymphocyte clones expressing dominant and subdominant TCR. Int Immunol. 13:1383-1390.
Lawson TM; Man S; Williams S; Boon AC; Zambon M; Borysiewicz LK. (Nov 2001). Influenza A antigen exposure selects dominant Vbeta17+ TCR in human CD8+ cytotoxic T cell responses. Int Immunol. 13:1373-1381.
Hart KW; Williams OM; Thelwell N; Fiander AN; Brown T; Borysiewicz LK; Gelder CM. (Sep 2001). Novel method for detection, typing, and quantification of human papillomaviruses in clinical samples. J Clin Microbiol. 39:3204-3212.
Tabi Z; Moutaftsi M; Borysiewicz LK. (1 May 2001). Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens. J Immunol. 166:5695-5703.
Adams M; Borysiewicz L; Fiander A; Man S; Jasani B; Navabi H; Lipetz C; Evans AS; et alMason M. (21 Mar 2001). Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer. Vaccine. 19:2549-2556.
Labéta MO; Vidal K; Nores JE; Arias M; Vita N; Morgan BP; Guillemot JC; Loyaux D; et alFerrara P; Schmid D; Affolter M; Borysiewicz LK; Donnet-Hughes A; Schiffrin EJ. (15 May 2000). Innate recognition of bacteria in human milk is mediated by a milk-derived highly expressed pattern recognition receptor, soluble CD14. J Exp Med. 191:1807-1812. Open Access copy.
Arias MA; Rey Nores JE; Vita N; Stelter F; Borysiewicz LK; Ferrara P; Labéta MO. (1 Apr 2000). Cutting edge: human B cell function is regulated by interaction with soluble CD14: opposite effects on IgG1 and IgE production. J Immunol. 164:3480-3486.
Tomasec P; Braud VM; Rickards C; Powell MB; McSharry BP; Gadola S; Cerundolo V; Borysiewicz LK; et alMcMichael AJ; Wilkinson GW. (11 Feb 2000). Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science. 287:1031.
Youde SJ; Dunbar PR; Evans EM; Fiander AN; Borysiewicz LK; Cerundolo V; Man S. (15 Jan 2000). Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens. Cancer Res. 60:365-371.
Smith AP; Borysiewicz L; Pollock J; Thomas M; Perry K; Llewelyn M. (Mar 1999). Acute fatigue in chronic fatigue syndrome patients. Psychol Med. 29:283-290.
Adams M; Navabi H; Jasani B; Evans A; Crosby T; Mason M; Borysiewicz L. (Sep 1997). Peptide loaded human autologous dendritic cells (DC's) as a potential anti-cancer vaccine. EUR J CANCER. 33:371-371.
Vita N; Lefort S; Sozzani P; Reeb R; Richards S; Borysiewicz LK; Ferrara P; Labéta MO. (1 Apr 1997). Detection and biochemical characteristics of the receptor for complexes of soluble CD14 and bacterial lipopolysaccharide. J Immunol. 158:3457-3462.
Navabi H; Jasani B; Adams M; Evans AS; Mason M; Crosby T; Borysiewicz L. (1997). Generation of in vitro autologous human cytotoxic T-cell response to E7 and HER-2/neu oncogene products using ex-vivo peptide loaded dendritic cells. Adv Exp Med Biol. 417:583-589.
Navimbi H; Jasani B; Adams M; Evans E; Mason M; Crosby T; Borysiewicz L. (Jul 1996). Feasibility of preparation of human dendritic cells (DC) from peripheral blood as a potential anti-tumour vaccine. BRIT J CANCER. 74:31-31.
Smith A; Pollock J; Thomas M; Llewelyn M; Borysiewicz L. (May 1996). The relationship between subjective ratings of sleep and mental functioning in healthy subjects and patients with chronic fatigue syndrome. HUM PSYCHOPHARM CLIN. 11:161-167.
Farmer A; Chubb H; Jones I; Hillier J; Smith A; Borysiewicz L. (Mar 1996). Screening for psychiatric morbidity in subjects presenting with chronic fatigue syndrome. Br J Psychiatry. 168:354-358.
Farmer A; Jones I; Hillier J; Llewelyn M; Borysiewicz L; Smith A. (Oct 1995). Neuraesthenia revisited: ICD-10 and DSM-III-R psychiatric syndromes in chronic fatigue patients and comparison subjects. Br J Psychiatry. 167:503-506.
LEHNER PJ; WANG ECY; GRAHAM S; MOSS PAH; FRIEDMAN SM; BELL JI; BORYSIEWICZ LK. (Mar 1994). CONSTRAINTS ON T-CELL RECEPTOR USAGE BY HUMAN INFLUENZA-A SPECIFIC CTL. FASEB J. 8:A240-A240.
Carmichael A; Jin X; Sissons P; Borysiewicz L. (1 Feb 1993). Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J Exp Med. 177:249-256.
Bell S; Cranage M; Borysiewicz L; Minson T. (May 1990). Induction of immunoglobulin G Fc receptors by recombinant vaccinia viruses expressing glycoproteins E and I of herpes simplex virus type 1. J Virol. 64:2181-2186.
RODGERS B; BORYSIEWICZ L; MUNDIN J; GRAHAM S; SISSONS P. (Sep 1987). IMMUNOAFFINITY PURIFICATION OF A 72K EARLY ANTIGEN OF HUMAN CYTOMEGALOVIRUS - ANALYSIS OF HUMORAL AND CELL-MEDIATED-IMMUNITY TO THE PURIFIED POLYPEPTIDE. J GEN VIROL. 68:2371-2378.
Rodgers B; Borysiewicz L; Mundin J; Graham S; Sissons P. (Sep 1987). Immunoaffinity purification of a 72K early antigen of human cytomegalovirus: analysis of humoral and cell-mediated immunity to the purified polypeptide. J Gen Virol. 68 ( Pt 9):2371-2378.
Bowman C; Green C; Borysiewicz L; Lockwood CM. (Aug 1987). Circulating T-cell populations during mercuric chloride-induced nephritis in the Brown Norway rat. Immunology. 61:515-520.
WEETMAN AP; GREEN C; BORYSIEWICZ LK. (1987). THE REGULATION OF IA-ANTIGEN EXPRESSION ON FRTL5 CELLS. ANN ENDOCRINOL-PARIS. 48:119-119.
Borysiewicz L; Krikler D. (2 May 1981). Scombrotoxic atrial flutter. Br Med J (Clin Res Ed). 282:1434.
BORYSIEWICZ L; KRIKLER D. (1981). SCOMBROTOXIC ATRIAL-FLUTTER. BRIT MED J. 282:1434-1434.
BORYSIEWICZ LK; SOUTAR A; EVANS DJ; REES AJ; THOMPSON GR. (1981). THE RELATIONSHIP OF RENAL ABNORMALITY TO PLASMA-LIPOPROTEINS IN FAMILIAL LECITHIN-CHOLESTEROL ACYL TRANSFERASE (LCAT) DEFICIENCY. Q J MED. 50:507-508.
HARPER PS; BORYSIEWICZ LK. (1976). NEWBORN SCREENING BLOOD-SAMPLE - VALUABLE SOURCE OF GENETIC DATA IN MAN. HEREDITY. 36:285-285.

Books

Beverley PCL; Borysiewicz LK; Hills AVS; Jones IG; Sissons JGP. Vaccinations. British Medical Bulletin/Oxford University Press (2002).
Sissons JGP; Cohen J; Borysiewicz LK. Immunology of Infection. MTP Press (1993).
Borysiewicz LK (Editor). Horizons in Medicine - Vol 2 - Advanced Medicine Symposium at Royal College of Physicians. 2. (1990).

Chapters in books

Borysiewicz LK. The host's response to infection. In Oxford Textbook of Medicine. 4th. Warrell DA (ed); Cox TM (ed); Firth JD (ed). Oxford University Press, Oxford (2003).